Elevated Plasma Fibrinogen Level Predicts Suboptimal Response to Therapy With Both Single- and Double-Bolus Eptifibatide During Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Elevated Plasma Fibrinogen Level Predicts Suboptimal Response to Therapy With Both Single- and Double-Bolus Eptifibatide During Percutaneous Coronary Intervention

Published:2007-06 Issue:22 Volume:49 Page:2163-2171
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Mahmud Ehtisham,Cavendish Jeffrey J.,Tsimikas Sotirios,Ang Lawrence,Nguyen Cuong,Bromberg-Marin Guilherme,Schnyder Guido,Keramati Shahin,Palakodeti Vachaspathi,Penny William F.,DeMaria Anthony N.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention;Kereiakes;Am J Cardiol,1999

2. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GP IIb/IIIa antibody in a canine preparation;Gold;Circulation,1988

3. Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention;Steinhubl;Circulation,1999

4. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty;Circulation,1997

5. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II;Lancet,1997

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Residual Platelet Reactivity on Clopidogrel Treatment and Severity of Coronary Atherosclerosis: Intrinsic Hypercoagulability as a Mediator;Advances in Therapy;2019-08-01

2. P2Y12 receptor inhibitors: an evolution in drug design to prevent arterial thrombosis;Expert Opinion on Drug Metabolism & Toxicology;2018-01-23

3. Effect of fibrinogen on platelet reactivity measured by the VerifyNow P2Y12 assay;Biochemistry (Moscow);2016-05

4. Recent Advances in Optimal Adjunctive Antithrombotic Therapy in STEMI Patients Undergoing Primary Angioplasty: An Overview;Current Vascular Pharmacology;2015-08-25

5. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial;EuroIntervention;2014-06